Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Dr. J who wrote (974)	5/12/1998 9:20:00 AM
From: David Winkler	Read Replies (2) \| Respond to of 2135

Little entremed worth $12/ share is turning up in some interesting places. Try the front page of IBD in an article on glasses and blindness!! It missed their company index list so you have to read the whole article. So we have a company that can prevent blindness in babies, old folks and cure cancer and folks get in line to short it at 30 certain it will go back to 12 while others pay $60+ per share. Somebody is wrong big time. I will guarantee you it will hit 60 again before it sees 12. It will be back in the original hands long before that.